Irhythm Technologies Stock Today
| IRTC Stock | USD 89.02 6.57 7.97% |
Performance7 of 100
| Odds Of DistressLess than 9
|
IRhythm Technologies is trading at 89.02 as of the 28th of November 2024, a 7.97 percent increase since the beginning of the trading day. The stock's open price was 82.45. IRhythm Technologies has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat ok performance during the last 90 days. Equity ratings for iRhythm Technologies are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of September 2024 and ending today, the 28th of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 20th of October 2016 | Category Healthcare | Classification Health Care |
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram monitoring products for patients at risk for arrhythmias in the United States. The company was incorporated in 2006 and is headquartered in San Francisco, California. The company has 31.3 M outstanding shares of which 2.74 M shares are currently shorted by private and institutional investors with about 3.46 trading days to cover. More on iRhythm Technologies
Moving together with IRhythm Stock
Moving against IRhythm Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
IRhythm Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO President | Quentin Blackford | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsIRhythm Technologies can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand IRhythm Technologies' financial leverage. It provides some insight into what part of IRhythm Technologies' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
iRhythm Technologies (IRTC) is traded on NASDAQ Exchange in USA. It is located in 699 8th Street, San Francisco, CA, United States, 94103 and employs 2,000 people. IRhythm Technologies is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.58 B. iRhythm Technologies conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 31.3 M outstanding shares of which 2.74 M shares are currently shorted by private and institutional investors with about 3.46 trading days to cover.
iRhythm Technologies currently holds about 204.49 M in cash with (50.1 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.81.
Check IRhythm Technologies Probability Of Bankruptcy
Ownership AllocationThe majority of iRhythm Technologies outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in IRhythm Technologies to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in iRhythm Technologies. Please pay attention to any change in the institutional holdings of iRhythm Technologies as this could imply that something significant has changed or is about to change at the company.
Check IRhythm Ownership Details
IRhythm Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Eventide Asset Management, Llc | 2024-09-30 | 736.7 K | |
| Geode Capital Management, Llc | 2024-09-30 | 733.3 K | |
| Morgan Stanley - Brokerage Accounts | 2024-06-30 | 709 K | |
| Amvescap Plc. | 2024-06-30 | 685.7 K | |
| Champlain Investment Partners, Llc | 2024-09-30 | 667.1 K | |
| Westfield Capital Management Company, Lp | 2024-09-30 | 528.3 K | |
| Bnp Paribas Investment Partners Sa | 2024-06-30 | 511.9 K | |
| Slate Path Capital Lp | 2024-09-30 | 510.5 K | |
| Millennium Management Llc | 2024-06-30 | 496 K | |
| Vanguard Group Inc | 2024-09-30 | 3.1 M | |
| Artisan Partners Limited Partnership | 2024-09-30 | 2.8 M |
IRhythm Technologies Historical Income Statement
IRhythm Stock Against Markets
IRhythm Technologies Corporate Management
| Chad Patterson | Chief Officer | Profile | |
| Brice CPA | Chief Officer | Profile | |
| Mazi Kiani | VP Regulatory | Profile | |
| Daniel Wilson | Executive Relations | Profile | |
| Mintu MD | Chief Officer | Profile | |
| MS MD | Chief Innovation | Profile | |
| Mervin Smith | Executive Operations | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iRhythm Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For information on how to trade IRhythm Stock refer to our How to Trade IRhythm Stock guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of IRhythm Technologies. If investors know IRhythm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about IRhythm Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.85) | Revenue Per Share 18.045 | Quarterly Revenue Growth 0.184 | Return On Assets (0.09) | Return On Equity (1.03) |
The market value of iRhythm Technologies is measured differently than its book value, which is the value of IRhythm that is recorded on the company's balance sheet. Investors also form their own opinion of IRhythm Technologies' value that differs from its market value or its book value, called intrinsic value, which is IRhythm Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IRhythm Technologies' market value can be influenced by many factors that don't directly affect IRhythm Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IRhythm Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if IRhythm Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IRhythm Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.